Immunological effect of early extra MMR immunization in infants between 6 and 12 months of age in an outbreak setting Immunologisch effect van een vroege extra BMR vaccinatie in zuigelingen tussen 6 en 12 maanden oud tijdens een uitbraak

Trial Profile

Immunological effect of early extra MMR immunization in infants between 6 and 12 months of age in an outbreak setting Immunologisch effect van een vroege extra BMR vaccinatie in zuigelingen tussen 6 en 12 maanden oud tijdens een uitbraak

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Oct 2013

At a glance

  • Drugs Measles mumps and rubella virus vaccine (Primary) ; Meningococcal vaccine group C conjugate (Primary)
  • Indications Measles; Meningococcal group C infections; Mumps; Rubella
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top